国际肿瘤学杂志 ›› 2013, Vol. 40 ›› Issue (3): 166-169.

• 综述 • 上一篇    下一篇

Toll样受体与癌症研究进展

王筱静, 梁桂玲, 王郡甫, 许晓群   

  1. 250062 济南,山东省医学科学院基础医学研究所 济南大学山东省医学科学院医学与生命科学学院(王筱静、王郡甫、许晓群);山东大学齐鲁医院(王筱静、梁桂玲)
  • 出版日期:2013-03-08 发布日期:2013-02-25
  • 通讯作者: 许晓群,E-mail: E-mail:xuxiaoqunsd@yahoo.com.cn
  • 基金资助:

    山东省自然科学基金(ZR2009CM036、ZR2010CM067、ZR2012HL23)

Toll-like receptors and cancer

WANG  Xiao-Jing, LIANG  Gui-Ling, WANG  Jun-Fu, XU  Xiao-Qun   

  1. Institute of Basic Medicine, Shandong Academy of Medical Sciences, Jinan University School of Medical and Life Sciences, Jinan 250062, China
  • Online:2013-03-08 Published:2013-02-25
  • Contact: Corresponding author: XU Xiao-qun, E-mail: xuxiaoqunsd@yahoo.com.cn E-mail:xuxiaoqunsd@yahoo.com.cn

摘要: Toll样受体家族(TLR)是重要的模式识别受体(PRR),参与固有免疫,调节适应性免疫。TLR表达于免疫细胞及多种恶性肿瘤细胞,识别保守的分子结构,介导炎症、组织损伤及组织修复,在肿瘤的进程中发挥重要作用。对TLR相关信号分子及信号通路的研究结果表明,TLR具有抗肿瘤及促肿瘤双重作用,在肿瘤的预防和治疗方面具有广阔前景。

关键词: 炎症, 肿瘤, 上皮, Toll样受体家族

Abstract: Toll-like receptor (TLR) is an important pattern recognition receptor (PRR) which participates in innate immunity and regulates adaptive immunity. TLR can be expressed in immune cells and malignant tumors recognize conservative molecular structure, mediate response of inflammation, tissue injury and repair, which plays an important role in the process of tumor. Research results about some molecules and signal pathways of TLR demonstrate that it can act anti or pro-tumor dual functions, which has an extensive prospects in prevention and treatment of tumor.

Key words: Inflammation, Neoplasms, Epithelium, Toll-like receptor